Annual Total Liabilities
$26.27 M
-$183.76 M-87.49%
December 31, 2023
Summary
- As of February 8, 2025, LXEO annual total liabilities is $26.27 million, with the most recent change of -$183.76 million (-87.49%) on December 31, 2023.
- During the last 3 years, LXEO annual total liabilities has fallen by -$8.67 million (-24.82%).
- LXEO annual total liabilities is now -87.49% below its all-time high of $210.03 million, reached on December 31, 2022.
Performance
LXEO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$34.54 M
+$7.48 M+27.64%
September 30, 2024
Summary
- As of February 8, 2025, LXEO quarterly total liabilities is $34.54 million, with the most recent change of +$7.48 million (+27.64%) on September 30, 2024.
- Over the past year, LXEO quarterly total liabilities has dropped by -$182.99 million (-84.12%).
- LXEO quarterly total liabilities is now -84.12% below its all-time high of $217.53 million, reached on September 30, 2023.
Performance
LXEO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LXEO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.5% | -84.1% |
| 3 y3 years | -24.8% | -84.1% |
| 5 y5 years | -24.8% | -84.1% |
LXEO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.5% | at low | -84.1% | +31.5% |
| 5 y | 5-year | -87.5% | at low | -84.1% | +31.5% |
| alltime | all time | -87.5% | at low | -84.1% | +31.5% |
Lexeo Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $34.54 M(+27.6%) |
| Jun 2024 | - | $27.06 M(-10.6%) |
| Mar 2024 | - | $30.25 M(+15.2%) |
| Dec 2023 | $26.27 M | $26.27 M(-87.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $217.53 M(+4.3%) |
| Jun 2023 | - | $208.56 M(-0.7%) |
| Dec 2022 | $210.03 M(+9.1%) | $210.03 M |
| Dec 2021 | $192.46 M(+450.7%) | - |
| Dec 2020 | $34.95 M | - |
FAQ
- What is Lexeo Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual total liabilities year-on-year change?
- What is Lexeo Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly total liabilities year-on-year change?
What is Lexeo Therapeutics annual total liabilities?
The current annual total liabilities of LXEO is $26.27 M
What is the all time high annual total liabilities for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual total liabilities is $210.03 M
What is Lexeo Therapeutics annual total liabilities year-on-year change?
Over the past year, LXEO annual total liabilities has changed by -$183.76 M (-87.49%)
What is Lexeo Therapeutics quarterly total liabilities?
The current quarterly total liabilities of LXEO is $34.54 M
What is the all time high quarterly total liabilities for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly total liabilities is $217.53 M
What is Lexeo Therapeutics quarterly total liabilities year-on-year change?
Over the past year, LXEO quarterly total liabilities has changed by -$182.99 M (-84.12%)